Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Tofacitinib is effective and safe for treating severe hair loss in a Saudi population.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Traditional Chinese medicine may help treat ischemic stroke by targeting specific genes and pathways.

Acupuncture may effectively treat long-standing alopecia areata.

A man's hair loss was linked to his HIV medication, which improved after changing drugs.

Using 5-α-reductase inhibitors before treatment improves outcomes for patients with metastatic renal cell carcinoma.

Aromatase inhibitors can cause various adverse reactions, so monitoring is crucial.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

The treatment showed promising results in improving advanced-stage hair loss.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Taking dutasteride for one month before prostate surgery can reduce bleeding.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Rivaroxaban may cause hair loss.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

The combination of cyproterone acetate and testosterone enanthate is highly effective in preventing sperm production and could be a good reversible male contraceptive.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

New regenerative therapies show promise for treating hair loss.

Group behavior therapy reduces hair-pulling symptoms more than supportive therapy but has limited long-term effectiveness.

New drug dutasteride effectively treats hair loss, but use cautiously due to potential sexual side effects.

PRP shows promise for hair loss treatment, with three initial monthly injections and maintenance every 3-6 months.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Baricitinib was effective in treating both early and late onset alopecia areata.